New studies reveal that optical genome mapping (OGM) can detect chromosomal abnormalities linked to recurrent pregnancy loss, ...

Thermo Fisher Scientific has introduced the Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer, designed for fast and scalable sample analysis. In conjunction with two new arrays – the Applied ...

There are two key things to know about the new Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer from Thermo Fisher Scientific, said Ravi Gupta, vice president and general manager of Thermo ...

Although alterations in several specific genes have been implicated in breast cancer progression, greater understanding of the molecular basis of the disease may result from the evaluation of global ...

Seasoned global pharmaceutical executive, Mr Brent MacGregor, joins Vaxxas Board to accelerate self-administered HD-MAP vaccines for global use;SPRIM Global Investment’s Co-Founder and Managing ...

The human brain is a highly complex structure, and its normal development and functioning is critically dependent on the proper and tightly regulated activity of a large number of genes. Indeed, ...

The biochip market size is calculated at USD 14.37 billion in 2025 and is expected to reach around USD 42.15 billion by 2034, ...

The data, which is being presented at this year's AMP meeting, offers some insights into the often hidden causes of recurrent pregnancy loss.

A new technology may allow patients to recover vision for conditions that were previously thought irreversible ...

Researchers have created a chip that's implanted in the eye, that with the help of AR glasses, can partially restore ...

With rapid advancements in whole genome sequencing, Kadam noted that genetic science is moving toward even more comprehensive ...